학술논문
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Document Type
Article
Author
Stephenson, Kathryn E; Tan, Chen Sabrina; Walsh, Stephen R; Hale, Andrew; Ansel, Jessica L; Kanjilal, Diane G; Jaegle, Kate; Peter, Lauren; Borducchi, Erica N; Nkolola, Joseph P; Makoni, Tatenda; Fogel, Rachel; Bradshaw, Connor; Tyler, Anna; Moseley, Edward; Chandrashekar, Abishek; Yanosick, Katherine E; Seaman, Michael S; Eckels, Kenneth H; De La Barrera, Rafael A; Thompson, Jason; Dawson, Peter; Thomas, Stephen J; Michael, Nelson L; Modjarrad, Kayvon; Barouch, Dan H
Source
In The Lancet Infectious Diseases September 2020 20(9):1061-1070
Subject
Language
ISSN
1473-3099